ENFUSE SOLUTIONS LIMITED vs HCL TECHNOLOGIES LTD

A side-by-side comparison of ENFUSE SOLUTIONS LIMITED (ENFUSE) and HCL TECHNOLOGIES LTD (HCLTECH) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, HCL TECHNOLOGIES LTD leads ENFUSE vs HCLTECH on 11 of 14 metrics (1 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

44.24
P/E ratio
19.63
7.68
P/B ratio
4.15
0.00%
Dividend yield
2.09%
₹3.67
EPS
₹61.33

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

-56.40%
Return on equity
24.00%
15.00%
Return on capital
31.00%
25.00%
EBITDA margin
21.00%
6.98%
Net margin
12.80%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

30.75%
Revenue CAGR (3Y)
8.65%
Profit CAGR (3Y)
3.90%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹168 Cr
Market cap
₹3.27L Cr
₹43 Cr
Revenue
₹1.30L Cr
₹3 Cr
Net profit
₹16,652 Cr
1.45
Debt / equity
0.07
ENFUSE SOLUTIONS LIMITED
  • + ["Debtor days have improved from 75.9 to 39.2 days."]
  • ["Stock is trading at 7.76 times its book value", "Company has low interest coverage ratio.", "Company has a low return on equity of -8.50% over last 3 years."]
HCL TECHNOLOGIES LTD
  • + ["Company is almost debt free.", "Stock is providing a good dividend yield of 4.64%.", "Company has been maintaining a healthy dividend payout of 90.6%"]
  • ["The company has delivered a poor sales growth of 11.5% over past five years."]
ENFUSE SOLUTIONS LIMITED full analysis HCL TECHNOLOGIES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

ENFUSE SOLUTIONS LIMITED vs HCL TECHNOLOGIES LTD: Share Price, Valuation & Which to Buy | DocStoX